Lexaria just completed dosing for its HYPER H21-4 human clinical study that dosed 64 patients aged between 40 and 70 with measured elevated blood pressure, stage 1 and stage 2 hypertension HYPER-H21-4, Lexaria’s most ambitious hypertension clinical study yet, builds on the success of HYPER-H21-1 and HYPER-H21-2, both completed in 2021 It explores the use … Continue reading “Lexaria Bioscience Corp. (NASDAQ: LEXX) Inches Closer to DehydraTECH-CBD FDA Evaluation Following Successful Dosing in Multi-Week HYPER-H21-4 Human Clinical Study”
Ontrak (NASDAQ: OTRK), a leading artificial intelligence and telehealth-enabled healthcare company, has closed its previously announced registered direct offering for $4 million. The offering was with institutional investors and involved the purchase and sale of shares of the company’s common stock at $0.80 per share. According to the announcement, the per-share purchase price was at-the-market … Continue reading “NetworkNewsBreaks – Ontrak Inc. (NASDAQ: OTRK) Closes on $4M Direct Offering”
Renewables are emerging as energy source that can secure limitless supply while reducing consumption of fossil fuels, dependence on exhaustible sources, and negative impact of rising oil costs Among them, solar could have essential role; it is world’s most reliable, abundant source of green power, providing cheapest electricity in history GeoSolar set to benefit as … Continue reading “GeoSolar Technologies Inc. Set to Benefit as Solar Gains Momentum with Potential to Become World’s Largest Source of Electricity by 2050”
FingerMotion’s launch of the mobile device protection product in the Chinese market looks to tap into an industry valued at approximately $10.6 billion annually The company has also partnered with an NYSE-listed insurance company looking to venture into the Chinese market and is confident that this, together with the product launch, will accelerate its revenue … Continue reading “FingerMotion Inc. (NASDAQ: FNGR) Banking on Device Protection Program and Partnerships to Accelerate Revenue Growth Over the Next 6-12 Months”
Investment Considerations CISO Global shares were listed on the Nasdaq in the first quarter of 2022. The company joined the broad-market Russell 2000 Index in June 2022. CISO Global posted a 376% revenue CAGR for the years 2019 through 2021. In 2021, 58% of the company’s revenue was recurring revenue from managed services contracts. CISO … Continue reading “CISO Global, Inc. (NASDAQ: CISO)”
Cepton Technologies (NASDAQ: CPTN) is reporting its financial results for the second quarter 2022, the period ended June 30, 2022; the report also included business updates for the Silicon Valley innovator and leader in high-performance Micro Motion Technology(RM) (“MMT”) lidar solutions. Highlights of the report included news of CPTN’s OEM Series production execution, including continued ramp … Continue reading “NetworkNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Releases Q2 2022 Financial Report, Corporate Update”
Lexaria’s patented DehydraTECH(TM) has 26 granted patents worldwide, including four in Japan Lexaria stands to gain substantial revenue through the licensing of DehydraTECH technology across minimum quarterly payments for license use by Premier and royalties for products sold By 2028, the CBD market is expected to reach US$47.22 billion, driven by increased demand for CBD … Continue reading “Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First Generation of CBD Products Under “Ko” Branding by Japanese Licensee Premier Wellness Science Co., Ltd.”
FingerMotion (NASDAQ: FNGR) reported a 37% year-over-year growth in revenue for the financial year ended Feb. 28, 2022 (“FY2022”). “One of our key initiatives is to keep pushing gross margins higher, and we have been quite successful by optimizing our product offerings,” a recent article quotes CEO Martin Shen’s comments from the release of the … Continue reading “NetworkNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Continues Strides to Push Gross Margins by Optimizing Product Offerings”
A recent Facts & Factors study reported that the global EV market is expected to pass $980 billion by 2028 Mullen posted the strongest balance sheet in company history for the quarter ended June 30, 2022 The company noted several key milestones in its journey to becoming a major presence in the EV world If … Continue reading “Mullen Automotive Inc. (NASDAQ: MULN) Anticipates Strongest Balance Sheet Ever as EV Industry Projected to See Double-Digit Growth”
Silo Pharma (OTCQB: SILO) recently announced it had produced an initial batch of SPU-21 liposomes for a rheumatoid arthritis study conducted by Frontage Laboratories, a contract research organization (“CRO”). “Recent research by the company revealed that SPU-21 liposomes have the ability to target inflamed epithelium, suggesting they can be used to target drug delivery. Further, … Continue reading “NetworkNewsBreaks – Silo Pharma Inc. (SILO) Reports Positive Results from Research on Novel Liposomes”
